Trial intelligence / Profile preview

Curodont vs ICON for Post Orthodontic White Spot Lesions

NCT07773714Phase 1Completed

Sponsor
Suez Canal University
Start
Apr 2023
Primary completion
May 2024
Countries
1
01

Overview

Phase 1, randomised trial of curodont in White spot lesion (WSL) (2 arms), sponsored by Suez Canal University. Primary endpoints: Number of Participants with White Spot Lesions post orthodontic treatment assessed by Delta E at 1 year and Delta E at 1 year. Started Apr 2023; status: completed.

02

Drugs

curodont
03

Conditions

White spot lesion (WSL)

Beyond the preview

Go deeper on NCT07773714.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07773714.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call